Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To determine the clinical benfit of aspirin and nadroparin versus asprin in the acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Prospective, randomized trial.

Contacts

Not available